Our Amgen Inc. (AMGN) ESG Review
| Symbol | AMGN |
| Price | $280.84 |
| 52 Week High 📈 | $346.85 |
| 52 Week Low 📉 | $253.30 |
| Earnings Per Share 💵 | 7.55 |
| Dividend Yield 🔁 | 3.39 |
Our Take
Amgen is a biotechnology pioneer and one of the world’s leading independent biotech companies. For more than 40 years, Amgen has pioneered cutting-edge science to transform the practice of medicine. Today, Amgen continues that mission by delivering medicines based on advances in cellular and molecular biology to patients in need worldwide.
The company’s broad portfolio of first-in-class and best-in-class medicines treats serious illnesses in six therapeutic areas: cardiovascular, immunology, oncology, osteoporosis, nephrology and neuroscience. With a deep and broad pipeline of potential new therapies, Amgen remains committed to advancing science to dramatically improve people’s lives.
Amgen’s ESG performance is strong overall, with a particularly good showing on environmental and social issues. On the environment front, Amgen has set ambitious goals for greenhouse gas emissions reductions and renewable energy usage, and has been recognized as one of the world’s top performers on the CDP Climate Change scoring system.
The company has also been recognized as a sector leader on water security by the Carbon Disclosure Project. On social issues, Amgen has been praised for its policies on employee health and safety, and for its efforts to develop medicines for underserved patient populations. However, the company’s score on governance is relatively weak, due in part to concerns about board diversity and executive compensation.
Has a strong product pipeline with potential blockbuster drugs in development
Is a leader in the biotechnology space and has a large market share
Has a good ESG rating
Its recent performance has been lacklustre
Faces stiff competition from other companies in the space
| Company | Amgen Inc. |
| Exchange | NASDAQGS |
| Address | One Amgen Center Drive,, Thousand Oaks, USA |
Popular ESG Stocks
| Stock | Marketcap | Industry | Price | Change % | 52 Week Range | Chart (24H) | EPS | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
 NVIDIA Corporation NVDA | 2.71T | Semiconductors | $111.01 | 4.30% | 2.94 | 0.04% | ||
 Microsoft Corporation MSFT | 2.91T | Software - Infrastructure | $391.85 | 1.17% | 12.42 | 0.85% | ||
 Best Buy Co., Inc. BBY | 14.31B | Specialty Retail | $67.71 | 2.59% | 4.28 | 5.61% | ||
 Adobe Inc. ADBE | 156.72B | Software - Application | $367.72 | 1.89% | 15.15 | 0.00% | ||
 Salesforce, Inc. CRM | 257.40B | Software - Application | $267.85 | 1.19% | 6.35 | 0.62% | ||
 Intuit Inc. INTU | 174.48B | Software - Application | $624.12 | 1.51% | 10.67 | 0.67% | ||
 Pool Corporation POOL | 11.00B | Industrial Distribution | $291.59 | 1.00% | 10.67 | 1.65% | ||
 PayPal Holdings, Inc. PYPL | 63.86B | Credit Services | $65.34 | 0.88% | 3.99 | 0.00% | ||
 Alphabet Inc. GOOGL | 1.95T | Internet Content & Information | $161.96 | 1.68% | 8.96 | 0.49% | ||
 First Solar, Inc. FSLR | 15.21B | Solar | $141.86 | 3.97% | 12.02 | 0.00% |
FAQ
How much is Amgen Inc. (AMGN) stock?
The current stock price of Amgen Inc. (AMGN) is $280.84.
What is Amgen Inc. (AMGN)'s ESG Score?
Amgen Inc. (AMGN) has an ESG score of 62, BBB, and aa as rated from Sustainalytics, ESG Enterprise, and MSCI, respectively.